Transaction DateRecipientSharesTypePriceValue
24th November 2020Keith Crandell1,034Other acquisition or disposition$0.00
24th November 2020Keith Crandell176,920Other acquisition or disposition$0.00
24th November 2020Keith Crandell277,514Other acquisition or disposition$0.00
20th November 2020Emily M. Leproust3,007Payment by withholding$115.56$347,488.92
20th November 2020James M Thorburn967Payment by withholding$115.56$111,746.52
20th November 2020Paula Green372Payment by withholding$115.56$42,988.32
20th November 2020Keith Crandell229,006Other acquisition or disposition$0.00
20th November 2020Mark Daniels744Payment by withholding$115.56$85,976.64
20th November 2020William Banyai675Payment by withholding$115.56$78,003.00
20th November 2020Keith Crandell854Other acquisition or disposition$0.00
Twist Bioscience
Twist Bioscience logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.


Twist Bioscience was founded by William Marine Banyai, Emily Marine Leproust and Bill James Peck in February 2013. It produces synthetic biology tools such as genes, oligo pools, variant libraries, DNA data storage and NGS.


Ticker: TWST
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1581280
Employees: 414
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals